BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7510927)

  • 1. Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia.
    Raife TJ; Lager DJ; Kemp JD; Dick FR
    Am J Clin Pathol; 1994 Mar; 101(3):296-9. PubMed ID: 7510927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of CD64, other monocyte-associated antigens, and CD45 gating in the subclassification of acute myeloid leukemias with monocytic differentiation.
    Krasinskas AM; Wasik MA; Kamoun M; Schretzenmair R; Moore J; Salhany KE
    Am J Clin Pathol; 1998 Dec; 110(6):797-805. PubMed ID: 9844593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of membrane CD11b, CD11c and CD14 expression in acute myeloid leukaemia: relationships with monocytic subtypes and the concept of relative antigen expression.
    Scott CS; Richards SJ; Master PS; Kendall J; Limbert HJ; Roberts BE
    Eur J Haematol; 1990 Jan; 44(1):24-9. PubMed ID: 1689668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.
    Dunphy CH; Tang W
    Arch Pathol Lab Med; 2007 May; 131(5):748-54. PubMed ID: 17488160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD163: a specific immunohistochemical marker for acute myeloid leukemia with monocytic differentiation.
    Garcia C; Gardner D; Reichard KK
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):417-21. PubMed ID: 18542032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
    Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
    Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic application of monoclonal antibody KB90 (CD11c) in acute myeloid leukaemia.
    Master PS; Richards SJ; Kendall J; Roberts BE; Scott CS
    Blut; 1989 Sep; 59(3):221-5. PubMed ID: 2477088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts.
    Leong CF; Raudhawati O; Cheong SK; Sivagengei K; Noor Hamidah H
    Pathology; 2003 Oct; 35(5):422-7. PubMed ID: 14555387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of CD19 as a marker of monocytic lineage in acute myelogenous leukemia.
    Tisone JA; Bohman JE; Theil KS; Brandt JT
    Am J Clin Pathol; 1997 Mar; 107(3):283-91. PubMed ID: 9052378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.
    Churchill HRO; Fuda FS; Xu J; Deng M; Zhang CC; An Z; Zhang N; Chen P; Bergstrom C; Kansagra A; Collins R; John S; Koduru P; Chen W
    Cytometry B Clin Cytom; 2021 Jul; 100(4):476-487. PubMed ID: 32918786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
    Willman CL; Stewart CC; Longacre TL; Head DR; Habbersett R; Ziegler SF; Perlmutter RM
    Blood; 1991 Feb; 77(4):726-34. PubMed ID: 1825181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
    Dubosc-Marchenay N; Lacombe F; Dumain P; Marit G; Montastruc M; Belloc F; Reiffers J
    Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].
    Sheng LX; Xie XB; Qiu GQ; Gu WY; Wang ZL; Wu HQ
    Ai Zheng; 2005 Nov; 24(11):1338-44. PubMed ID: 16552959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies.
    Horny HP; Wehrmann M; Steinke B; Kaiserling E
    Hum Pathol; 1994 Aug; 25(8):810-4. PubMed ID: 8056422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of monoclonal antibody Y1/82A in the identification of acute myeloblastic and monocytic leukemias.
    Davey FR; Erber WN; Gatter KC; Mason DY
    Am J Clin Pathol; 1988 Jan; 89(1):76-80. PubMed ID: 3422117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry immunophenotypic characteristics of monocytic population in acute monocytic leukemia (AML-M5), acute myelomonocytic leukemia (AML-M4), and chronic myelomonocytic leukemia (CMML).
    Gorczyca W
    Methods Cell Biol; 2004; 75():665-77. PubMed ID: 15603447
    [No Abstract]   [Full Text] [Related]  

  • 20. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
    Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
    Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.